Concerned is a specific lot of the drug Telmisartan Alter generic after have been Detected values out of specification in the dissolution test during stability studies.
Infarmed determined the immediate suspension of the commercialization of a specific lot of the drug Telmisartan Alter Generics, 80 mg, Following a voluntary collection by the company Alter Genericas – commercialization of LDA generic products.
Numa no site da National drug authority, concerned is the fact that they have been Detected values out of specification in the dissolution test during stability studies.
O Lot in question is the A001avalid until February 2027.
According to Infarmedentities that have this plot of medicine in stock cannot sell, dismiss or administer, should return it to the manufacturer.
Patients who use this medicine should maintain treatment, but move to the doctor to change the lot to another or consider one therapeutic equivalent.
Telmisartan is used to treat hypertension and In reducing cardiovascular events such as heart attack or stroke in patients who are at risk.
